“Corporate venture arm investing in biotechnology and pharmaceutical companies that align with AbbVie's therapeutic areas.”
Alphabet's research and development biotech company focused on aging and longevity research.
A therapeutics company focused on pharmaceutical or medical technology development with limited public information available.
Biopharmaceutical company developing engineered protein therapeutics for cancer using expanded genetic code technology.
AbbVie has built a portfolio of 3 companies across 1 sector, including Biotech.
AbbVie has invested in 3+ companies across 1 different sectors.
AbbVie's portfolio spans Biotech. This diversification reflects the firm's broad investment thesis and sector expertise.
Archstone
Fund admin, LP portal, capital calls, distributions, and reporting in one place. Purpose-built for emerging fund managers. Starting at $297/mo.
See Archstone